19 results on '"Monkhorst K"'
Search Results
2. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics
3. Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatments
4. Prediction of response to anti-PD-1 therapy in patients with non-small-cell lung cancer by electronic nose analysis of exhaled breath
5. Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
6. 40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?
7. 1723P Improving access to molecular tumour boards for complex genomic profiles: A healthcare policy from the Netherlands
8. 1249P Whole genome sequencing-based cancer diagnostics in routine clinical practice: An interim analysis of two years of real-world data
9. 1673P Exploring different strategies to incorporate germline analysis in tumor whole genome sequencing
10. 1075P Tobacco smoking related mutational signatures (MS) in classifying smoking and non-smoking associated metastatic non-small cell lung cancer (mNSCLC)
11. 1045P Comprehensive genomic profiling to guide immunotherapy in lung cancer
12. 1740P Track and treat in NSCLC (TATIN) - ctDNA guided treatment of early resistance to second-line osimertinib treatment in patients with EGFR mutation positive (EGFRm) NSCLC
13. 1133P Whole genome sequencing can classify diagnostically challenging tumors
14. 1189O Validation of whole genome sequencing in routine clinical practice
15. 1408P - WGS implementation in standard cancer diagnostics for every cancer patient (WIDE)
16. 473P - Phase I study of lapatinib and trametinib in patients with KRAS mutant colorectal, non-small cell lung and pancreatic cancer
17. 1450P - Osimertinib treatment for patients with EGFR exon 20 insertion positive non-small cell lung cancer
18. PO-221 Mouse models of lung squamous cell carcinoma for preclinical intervention studies
19. 1630PD - Association of programmed cell death 1 ligand (PD-L1) expression with molecular alterations in non-small cell lung cancer (NSCLC) patients (pts): Results from the European Thoracic Oncology Platform (ETOP) Lungscape cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.